Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term antidepressant treatment.

Katia K Delrahim1, Rachel Maddux, Mark Hyman Rapaport

  • 1Department of Psychiatry, University of California, San Diego, California, USA.

Psychopharmacology Bulletin
|July 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cendakimab (anti-IL-13) administration improves esophageal gene expression in eosinophilic esophagitis.

The Journal of allergy and clinical immunology·2025
Same author

Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials.

European journal of neurology·2025
Same author

Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.

Digestive diseases and sciences·2024
Same author

SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis.

Annals of clinical and translational neurology·2023
Same author

Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial.

Brain, behavior, & immunity - health·2023
Same author

A preliminary descriptive report of the longevity of the effects of Swedish Massage therapy for subjects with Generalized Anxiety Disorder.

Journal of bodywork and movement therapies·2023

Major depressive disorder (MDD) is often lifelong. Long-term antidepressant treatment may prevent future depressive episodes, especially after incomplete acute treatment response.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • Major depressive disorder (MDD) is a prevalent and burdensome mental health condition.
  • Emerging evidence indicates MDD frequently becomes a chronic, lifelong illness for many individuals.
  • Identifying factors that increase the risk of relapse and recurrence is crucial for effective long-term management.

Purpose of the Study:

  • To investigate risk factors for increased relapse and recurrence in major depression.
  • To explore therapeutic strategies aimed at enhancing acute treatment response in MDD patients.
  • To evaluate the efficacy of long-term antidepressant treatment in preventing MDD relapse and recurrence.

Main Methods:

  • Review of recent research on risk factors for major depressive disorder (MDD) relapse.

Related Experiment Videos

  • Analysis of data from clinical trials examining acute treatment enhancement techniques.
  • Assessment of continuation and maintenance treatment protocols for MDD.

    • Main Results:

    • Incomplete response to acute treatment is a significant risk factor for MDD relapse and recurrence.
    • Continuation treatment following acute therapy offers protection against returning to a depressive episode.
    • Maintenance treatment with antidepressants appears to prevent the development of new MDD episodes.

    Conclusions:

    • Long-term antidepressant therapy, including continuation and maintenance phases, is vital for managing chronic major depressive disorder.
    • Enhancing acute treatment response may be a key strategy in preventing long-term illness progression.
    • Further research into lifelong management strategies is warranted for major depressive disorder patients.